mizoribine has been researched along with Glomerulonephritis, Minimal Change in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manabe, S; Nagata, M; Nitta, K | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Cho, BS; Hahn, WH; Kim, SD; Park, SS | 1 |
| Hirayama, K; Kobayashi, M | 1 |
| Fujita, S; Iharada, A; Kaneko, K; Miyazaki, K; Okada, M; Sakata, N; Sugimoto, K; Takemura, T; Tsuji, S; Yanagida, H | 1 |
| Akashi, S; Fujinaga, S; Kaneko, K; Murakami, H; Ohtomo, Y; Shimizu, T; Takada, M; Yamashiro, Y | 1 |
| Gomi, H; Ishimoto, F; Matsuda, H; Sakai, O; Shibasaki, T; Usui, M | 1 |
2 review(s) available for mizoribine and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2018 |
[Minimal change nephrotic syndrome].
Topics: Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Proteinuria; Pulse Therapy, Drug; Ribonucleosides | 2010 |
5 other study(ies) available for mizoribine and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Remission of refractory minimal change nephrotic syndrome after basiliximab therapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Basiliximab; Child, Preschool; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrosis, Lipoid; Recombinant Fusion Proteins; Ribonucleosides | 2009 |
GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.
Topics: Adolescent; Biomarkers; Biopsy; Child; Comparative Genomic Hybridization; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glutathione Transferase; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Mutation; Nephrosis, Lipoid; Polymerase Chain Reaction; Proteinuria; Reactive Oxygen Species; Ribonucleosides; T-Lymphocytes, Helper-Inducer; Treatment Outcome | 2012 |
High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Topics: Adolescent; Adult; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Ribonucleosides; Secondary Prevention; Time Factors; Treatment Outcome | 2005 |
Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
Topics: Animals; Antibiotics, Antineoplastic; Immunosuppressive Agents; Male; Nephrosis; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides; Thromboxane B2 | 1996 |